Mediclinic International PLC (LON:MDC) had its price target lowered by research analysts at Jefferies Group from GBX 920 ($12.01) to GBX 833 ($10.87) in a report released on Thursday. The firm presently has a “hold” rating on the stock. Jefferies Group’s price objective suggests a potential downside of 9.95% from the stock’s current price.

Several other brokerages have also recently issued reports on MDC. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a GBX 1,160 ($15.14) price objective on shares of Mediclinic International PLC in a research note on Tuesday, August 23rd. Citigroup Inc. upgraded Mediclinic International PLC to a “buy” rating and lifted their price objective for the company from GBX 990 ($12.92) to GBX 1,150 ($15.01) in a research note on Tuesday, June 28th. Finally, Macquarie reiterated a “neutral” rating and issued a GBX 900 ($11.75) price objective on shares of Mediclinic International PLC in a research note on Friday, May 27th. Seven research analysts have rated the stock with a hold rating and one has given a buy rating to the company. Mediclinic International PLC currently has an average rating of “Hold” and a consensus price target of GBX 967.43 ($12.63).

Analyst Recommendations for Mediclinic International PLC (LON:MDC)

Mediclinic International PLC (LON:MDC) opened at 926.50 on Thursday. The company has a 50-day moving average of GBX 1,029.15 and a 200 day moving average of GBX 961.26. The firm’s market cap is GBX 6.83 billion. Mediclinic International PLC has a one year low of GBX 794.50 and a one year high of GBX 1,219.00.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/22/mediclinic-international-plc-mdc-pt-lowered-to-gbx-833.html

Mediclinic International PLC Company Profile

Mediclinic International plc, formerly Al Noor Hospitals Group plc, is a holding company. The Company operates as an international private healthcare provider. Its segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services.

Receive News & Ratings for Mediclinic International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International PLC and related companies with MarketBeat.com's FREE daily email newsletter.